Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan Rogel Cancer Center
- Study ID
- NCT05965180
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 40 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Fine Needle Photoacoustic Probe — DEVICEFine Needle Photoacoustic Probe guided by the standard biopsy system without tissue core extraction
Study Details
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.
Key Dates
- Start date
- Oct 16, 2023
- Status verified
- Nov 2025
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: BiopsyPatients will be identified once prostate biopsies have been scheduled. Once enrolled on trial, patients will undergo standard biopsy procedure as per clinical care. During this biopsy, research measurements will be completed using the fine needle photoacoustic probe.
Primary Outcome Measure
Demonstration of reliable measurements [ Time Frame: day 1 ]
Central Contacts
- Cancer AnswerLine1-800-865-1125
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | Guan Xu, Phd (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
By condition
By specialty
By research site
Related Studies
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama
- EDRN Prostate MRI Biomarker StudyRecruiting · University of Michigan · Ann Arbor, Michigan
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- Precision-Based Genomics in Prostate CancerRecruiting · National Cancer Institute (NCI) · La Jolla, California